Home › NDC Lookup › Ingredients › Petrolatum › 11701-0048-24
Baza Clear Petrolatum 960 mg/g Ointment, 50 g — NDC 11701-0048-24 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Baza Clear Petrolatum 960 mg/g Ointment, 50 g — NDC 11701-048-24 (Billing 11701-0048-24)

by Coloplast Corp · 50 g in 1 TUBE

This is a package of 50 g of Baza Clear Petrolatum 960 mg/g Ointment from Coloplast Corp, marketed since Jun 2009 and currently FDA-listed.

NDC 11701-0048-24
🏷️ FDA NDC (as labeled) 11701-048-24 billing pads the product segment with a zero
This package
Contains50 g Pack sizes3 compare ↓
Product page 11701-0048-14 Also comes in: 4 g 11701-048-22 142 g 11701-048-14
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 8, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 11701-048-24 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
11701 labeler · 048 product · 24 package
Package marketed since
Jun 15, 2009
Sample package
No — commercial package
Listing certified through
Dec 31, 2027
Billing quantity
50 g per package
Barcode (UPC-A, from the NDC)
3 1170104824 7
FDA record last changed
Jul 24, 2026

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 11701-048-24
Product NDC 11701-048
11-digit billing NDC 11701004824
NCPDP billing unit GM — per gram (weight)
RxCUI 686454, 1085651
UNII 4T6H12BN9U
Application # M016
SPL Set ID 69d9f456-1a35-4146-8366-c0285648a172
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2009-06-15
Route TOPICAL
Dosage form OINTMENT
Substance PETROLATUM

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GPI-14 90650040004200
GPI class Baza Clear
GCN Seq No 059980
GCN 25929
HICL code 033302
Ingredient (HICL) Cod Liver/Vit A,D/Petrolat,Wht
HIC1 code L
Therapeutic class — broad (HIC1) Skin/Subcutaneous Tissue
HIC2 code L3
Therapeutic class — intermediate (HIC2) Protectives
HIC3 code L3A
Therapeutic class — specific (HIC3) Protectives
AHFS code 84:24.12.00
AHFS class Basic Ointments And Protectants
FDB label name BAZA CLEAR OINTMENT
FDB brand name Baza Clear
Legend status O — Over-the-counter (OTC) drug or device
Quick answers
  • GSN (GCN sequence number): 059980
  • GCN: 25929
  • GPI-14 (Medi-Span): 90650040004200
  • HICL (First Databank): 033302
  • AHFS class code: 84:24.12.00
  • RxCUI (RxNorm): 686454
Why two NDCs? The FDA registers this code as 11701-048-24 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 11701-0048-24. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

Clinical

Label name BAZA CLEAR OINTMENT Ingredient Cod Liver/Vit A,D/Petrolat,Wht
🧪 What is this product?

Baza Clear is a petrolatum-based ointment applied to the skin. Petrolatum is a mineral oil-based occlusive commonly used to help protect and soften skin by creating a moisture barrier. This product is marketed as an over-the-counter monograph drug, meaning it is sold under FDA category rules for skin protectant products rather than as an individually approved medicine.

Supplement & herbal interactions

Some supplements/herbs that may interact with Petrolatum — tap one for details:

Dimethylsulfoxide (dmso)Moderate Turpentine OilModerate AlchemillaMinor
🌿 Every supplement checked against Petrolatum (3 interactions) — ranked by severity →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer gPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Try another pack size: 4 g 142 g
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
11701-0048-14 11701-048-14 Main listing 142 g in 1 TUBE 2009-06-15 — Active
11701-0048-22 11701-048-22 4 g in 1 PACKET 2009-06-15 — Active
11701-0048-24 You're viewing this 50 g in 1 TUBE 2009-06-15 — Active

You're viewing one of 3 pack sizes for this product.

Pack size FAQ

What quantity is in this package?
This package contains 50 g — 50 g in 1 tube.
How does this package differ from NDC 11701-0048-22?
Both are Baza Clear Petrolatum 960 mg/g Ointment — the drug itself is identical. This page's package is the 50 g one, while NDC 11701-0048-22 is the 4 g package.
What NDC number is used to bill for this package of Baza Clear Petrolatum 960 mg/g Ointment?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Baza Clear 960 mg/gthis 11701-0048-24 Coloplast 50 g — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2009
On the market since
Jun 2009
📍
2026
Currently FDA-listed
17 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII PH41D05744
    A synthetic antimicrobial chemical compound used as a preservative in medicines and personal care products. It prevents bacterial and fungal growth to keep the product safe during storage and use.
  • UNII 1P9D0Z171K
    BHT is a synthetic antioxidant that prevents fats and oils in medicines from breaking down and becoming rancid. It helps keep the product stable and effective during storage.
  • UNII BBL281NWFG
    Cod liver oil is a natural oil derived from fish liver that serves as a source of omega-3 fatty acids and vitamins A and D in formulations. It's used as a nutrient supplement ingredient and as an emollient to help soften and smooth the product.
  • UNII 4QP5U84YF7
    A synthetic green colorant used to tint medicines and make them visually distinctive. It helps identify the medication and may improve appearance of tablets or capsules.
  • UNII 7473P66J9E
    Sodium caseinate is a protein derived from milk that acts as a binder and emulsifier in medicines. It helps hold ingredients together and keeps oils and water mixed evenly throughout the product.

5 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statesInactive ingredients benzethonium chloride, BHT, cod liver oil, fragrance, green 6, sodium caseinate (CONTAINS MILK) See crimp for lot no. and expiration date Manufactured by: Coloplast A/S DK-3050 Humlebaek, Denmark Distributed by: Coloplast Corp. Minneapolis, MN 55411 U.S.A. 1-800-533-0464 www.us.coloplast.com Product #1006 ©2008-7, Coloplast Corp. Made in the U.S.A. G8-303

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerColoplast Corp
FDA applicationM016 (OTC MONOGRAPH DRUG)
Labeler code11701
First marketedJun 2009
Product typeHuman Otc Drug
Portfolio16 products on file

More NDCs from Coloplast Corp labeler code 11701

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Ask a Doctor Before Use If 📄 When Using This Product 📄 Keep Out of Reach of Children 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 26 words ▾

Uses Helps treat and prevent minor skin irritation due to diaper rash. Helps prevent and temporarily protects chafed, chapped or cracked skin. Helps seal out wetness.

⏱️ Dosage and Administration 42 words ▾

Directions apply liberally as often as necessary. For Diaper Rash: cleanse the diaper area and allow to dry apply liberally as often as necessary, with each diaper change especially at bedtime or any time when exposure to wet diapers may be prolonged.

⚠️ Warnings 1 words ▾

Warnings

🧪 Active Ingredient 4 words ▾

Active ingredient Petrolatum, 96%

🧪 Inactive Ingredients 50 words ▾

Inactive ingredients benzethonium chloride, BHT, cod liver oil, fragrance, green 6, sodium caseinate (CONTAINS MILK) See crimp for lot no. and expiration date Manufactured by: Coloplast A/S DK-3050 Humlebaek, Denmark Distributed by: Coloplast Corp. Minneapolis, MN 55411 U.S.A. 1-800-533-0464 www.us.coloplast.com Product #1006 ©2008-7, Coloplast Corp. Made in the U.S.A. G8-303

🎯 Purpose 3 words ▾

Purpose Skin Protectant

📄 Ask a Doctor Before Use If 13 words ▾

Consult a doctor if condition worsens or does not improve within 7 days.

📄 When Using This Product 19 words ▾

When using this product avoid contact with eyes not to be applied over deep or puncture wounds or lacerations.

📄 Keep Out of Reach of Children 23 words ▾

Keep this and all drugs out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

📄 Package Label / Principal Display Panel 41 words ▾

PRINCIPAL DISPLAY PANEL - NET WT. 5 OZ. (142g) NDC 11701-048-014 Baza ® Clear Skin Protectant Moisture Barrier Ointment For Skin Irritation Due to Incontinence Coloplast NET WT. 5 OZ. (142 g) PRINCIPAL DISPLAY PANEL - NET WT. 5 OZ. (142g)

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Petrolatum — the ingredient across all brands.

Top reported reactions

Eye Irritation358
Eye Pain333
Vision Blurred263
Ocular Hyperaemia229
Dry Eye218
Nausea140
Diarrhoea135

Age at onset

Neonate7
Infant11
Child23
Adolescent16
Adult252
Elderly356

Reporter sex

3,434 reports
Male · 35%
Female · 64%
Unknown · 0%

Serious outcomes

Hospitalization990
Death278
Life-threatening173
Disabling84
Reports over time (by year) — tap or hover for the count & year
2019 2021 2023 2026 231 0
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

About this NDC listing & data coverage

Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Coloplast Corp. Listing status can change — the directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 2 other package presentations of this same product, including 4 g (11701-0048-22), 142 g (11701-0048-14). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
Coloplast Corp is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 11701-0047-05 · Coloplast 11701-0050-32 · Coloplast →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.